A pacemaker from Medtronic, newly approved by the Food and Drug Administration, allows patients to securely transmit data from the pacemaker to their physicians via a smartphone or tablet using ...

FDA Approves New ICDs and CRT-Ds with Advanced Remote Capabilities DUBLIN, May 08, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced results from late-breaking clinical trials ...

Medtronic has received FDA clearance for a mobile app that allows patients to remotely forward data from their pacemakers with their physicians. The app is paired with a device, the MyCareLink Smart ...

The list of smartphone capabilities seems to expand daily and now, for patients with an implantable pacemaker from Medtronic Plc (Dublin), there is even a mobile app designed to monitor the device ...

December 8, 2011 (Rennes, France) — Remote monitoring of patients with dual-chamber pacemakers "was a safe substitute for conventional follow-ups, decreased the number of [clinic] visits, and enabled ...

Medtech company Medtronic has partnered with remote patient monitoring company BioIntelliSense to have the distribution rights of the BioButton across the U.S. The BioButton is a remote monitoring ...

Dublin, Sept. 01, 2025 (GLOBE NEWSWIRE) -- The "AI in Remote Patient Monitoring (RPM) - Company Evaluation" report has been added to ResearchAndMarkets.com's offering. The AI in Remote Patient ...

DUBLIN, Jan. 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has received CE (Conformité Européenne) Mark for its Micra™ AV2 and Micra™ ...

DUBLIN, Jan. 10, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has received approval from Japan's Ministry of Health, Labor and Welfare ...

Dublin, Sept. 01, 2025 (GLOBE NEWSWIRE) -- The "Remote Patient Monitoring (RPM) - Company Evaluation Report" report has been added to ResearchAndMarkets.com's offering. The Remote Patient Monitoring ...

The first unexpected power failure in a Medtronic InSync III pacemaker didn't set off the alarm bells. But by the fourth time, doctors at the Minneapolis Heart Institute knew they had to act quickly.